← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2016-11-21

Drug application

FDA Application #

ANDA077695

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

LAMIVUDINE

Active ingredients

LAMIVUDINE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Rising Pharma Holdings, Inc.

First approval

2016-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown